新華聯資本(00758.HK)控股股東聯繫人遭司法重整申請受理
新華聯資本(00758.HK)公布,公司獲執行董事及最終控股股東傅軍的聯繫人新華聯控股通知,北京市第一中級人民法院已受理湖南富興集團對新華聯控股提出的司法重整申請,涉及總額3,000萬元人民幣加應計利息,因新華聯控股無法償還其到期債務,但該公司具有重整可能和潛在重整價值。
新華聯資本強調,公司及其附屬公司業務穩健,重整申請不針對集團或其資產提出,又指相關重整程序現處於初步階段,其結果存在不確定性,將會繼續評估重整對集團的持續影響。
股份自今年2月15日起暫停買賣,並將繼續停牌直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.